14397-64-9

Basic information

• Product Name: Ethyl 2-oxo-1-indanecarboxylate
• Synonyms: 2-Oxo-1-indanecarboxylic acid ethyl ester;Ethyl 2-oxo-1-indanecarboxylate;ethyl 2-oxo-2,3-dihydro-1H-indene-1-carboxylate
• CAS NO: 14397-64-9
• Molecular Formula: C₁₂H₁₂O₃
• Molecular Weight: 204.22
• Mol File: 14397-64-9.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethyl 2-oxo-1-indanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-oxo-1-indanecarboxylate(14397-64-9)
• EPA Substance Registry System: Ethyl 2-oxo-1-indanecarboxylate(14397-64-9)

Safety Data

• Hazardous Substances Data: 14397-64-9(Hazardous Substances Data)

Upstream product

• 613-73-0 1,2-phenylenediacetonitrile 
• 17532-66-0 ethyl 2-[2-(2-ethoxy-2-oxoethyl)phenyl]acetate 
• 71-43-2 benzene 
• 141-52-6 sodium ethanolate 

Downstream Products

• 7500-53-0 1,2-Phenylenediacetic acid 
• 615-13-4 2-indanone 
• 1126602-63-8 N₄-(4-chloro-2-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-62-7 N₄-(3-chloro-4-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-59-2 N₄-(3-methoxyphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-58-1 N₄-(4-(trifluoromethyl)phenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-57-0 N₄-(4-bromophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-61-6 N₄-(3-bromophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-56-9 N₄-(4-chlorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-54-7 N₄-(3-chlorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-55-8 N₄-(4-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-53-6 N₄-(3-fluorophenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-52-5 N₄-(4-isopropylphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 
• 1126602-51-4 N₄-(2-isopropylphenyl)-9H-indeno[2,1-d]pyrimidine-2,4-diamine 

Relevant articles and documents

Novel tricyclic indeno[2,1-d]pyrimidines with dual antiangiogenic and cytotoxic activities as potent antitumor agents

We designed, synthesized and evaluated 13 novel tricyclic indeno[2,1-d]pyrimidines as RTK inhibitors. These analogues were synthesized via a Dieckmann condensation of 1,2-phenylenediacetonitrile followed by cyclocondensation with guanidine carbonate to af

Benzobicycloalkane ketones

Benzobicycloalkane amines, their pharmacologically acceptable addition salts, intermediates therefore the processes for their preparation and use. The compounds of the invention exert analgesic and anti-inflammatory activity.